- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Mesothelioma, Small Cell Lung Cancer, NSCLC in New Zealand
Total 1657 results
-
Taiho Oncology, Inc.RecruitingAdvanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) MutationsUnited States, Japan, Spain, France, Australia, Italy, Korea, Republic of, United Kingdom, Canada, Germany, Turkey, Hong Kong
-
GlaxoSmithKlineTerminated
-
Syndax PharmaceuticalsTerminatedNon Small Cell Lung CancerUnited States
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CancerMexico, Italy, Australia, Spain
-
AVEO Pharmaceuticals, Inc.Biodesix, Inc.TerminatedNon-small Cell Lung CancerKorea, Republic of, United States, Australia, Taiwan, Singapore, Hong Kong, Italy
-
Hummingbird BioscienceMerck KGaA, Darmstadt, GermanyRecruitingAdvanced or Metastatic Squamous Non-Small Cell Lung CancerAustralia, Singapore
-
Genentech, Inc.CompletedNon-small Cell Lung CancerUnited States
-
Novartis PharmaceuticalsCompletedAdvanced Non-small Cell Lung Cancer and MET Exon 14 Skipping MutationUnited States
-
GlaxoSmithKlineCompletedNon-Small-Cell Lung CancerUnited States, Belgium, United Kingdom
-
YM BioSciencesCIMYM BioSciencesTerminatedNon-small-cell Lung CancerCanada, United States, Singapore
-
SCRI Development Innovations, LLCAchieve Life SciencesCompletedNon Squamous Non Small Cell Lung CancerUnited States
-
AmgenActive, not recruitingSquamous-Cell Non-Small-Cell Lung CancerFrance, Belgium, Spain, United States, Taiwan, Korea, Republic of, Japan, Poland
-
GlaxoSmithKlineCompletedSmall Cell Lung Cancer | Lung Cancer, Small CellUnited States
-
Arcus Biosciences, Inc.Gilead SciencesActive, not recruitingNon Small Cell Lung Cancer | Nonsquamous Nonsmall Cell Neoplasm of Lung | Non Small Cell Lung Cancer Metastatic | Sensitizing EGFR Gene MutationUnited States, Korea, Republic of, Singapore, Taiwan
-
Proacta, IncorporatedTerminatedNon-Small Cell Lung CancerUnited States, Canada, New Zealand
-
Ariad PharmaceuticalsTakedaActive, not recruitingALK-positive Advanced NSCLCKorea, Republic of, United States, Spain, Taiwan, Canada, Hong Kong, China, Sweden, Australia, Italy, Japan, Germany, Netherlands, France, Austria
-
Peregrine PharmaceuticalsCompletedNon-Squamous Non-Small Cell Lung CancerUnited States, India, Georgia, Russian Federation, Ukraine
-
Novartis PharmaceuticalsRecruitingNon-small Cell Lung CancerUnited States, Korea, Republic of, Spain, Japan, Germany, Switzerland
-
Albert Einstein College of MedicineNational Cancer Institute (NCI); Eli Lilly and Company; OSI PharmaceuticalsCompletedStage IIIB Non-Small Cell Lung Cancer | Lung Adenocarcinoma | Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer | Bronchioloalveolar Carcinoma | Large Cell Lung CarcinomaUnited States
-
Infinity Pharmaceuticals, Inc.CompletedNon Small Cell Lung CancerUnited States, Hungary, Taiwan, Korea, Republic of, Russian Federation, Romania
-
UNC Lineberger Comprehensive Cancer CenterTerminatedStage IIIA Non-Small Cell Lung CancerUnited States
-
7 Hills Pharma, LLCNot yet recruitingMelanoma | Kidney Cancer | Renal Cell Carcinoma | Hepatocellular Carcinoma | Colorectal Cancer | NSCLC | Non Small Cell Lung Cancer | Skin Cancer | Metastasis | Advanced Solid Tumor | Advanced Cancer | Renal Cell Cancer | Hepatocellular Cancer | Mismatch Repair Deficiency | Pleural Mesothelioma | MSI-High | Anaplastic Lymphoma... and other conditionsUnited States
-
BeiGeneRecruitingNon-small Cell Lung Cancer | Metastatic Non-small Cell Lung CancerUnited States, China, Australia, Spain, Malaysia, Italy, Canada, Thailand, Georgia, Brazil, Korea, Republic of, Singapore, Moldova, Republic of, Romania
-
Shanghai Henlius BiotechRecruitingExtensive Stage Small Cell Lung CancerUnited States
-
PfizerTerminatedNon-small Cell Lung Cancer | Urothelial CancerSpain, Czechia, United States, Australia, United Kingdom, Italy, Canada, Hungary
-
Gilead SciencesArcus Biosciences, Inc.RecruitingLung Cancer | Advanced or Metastatic Non-Small-Cell Lung Cancer | Resectable Non-Small-Cell Lung CancerUnited States, Korea, Republic of, Taiwan, Hong Kong, Israel, United Kingdom
-
Eli Lilly and CompanyCompletedNon-small Cell Lung CancerItaly, United States, Germany, Poland, Belgium, United Kingdom
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyActive, not recruitingAdvanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification | Lung Adenocarcinoma Stage IIIB/IVSpain, Taiwan, United States, Korea, Republic of, Netherlands, Israel, Belgium, Italy, China, France, Germany, Japan, Poland, Austria, Switzerland
-
Ethicon, Inc.WithdrawnNon-Small Cell Lung Cancer | Lung Cancer | Neoplasms, Lung | Carcinoma, Non-Small Cell Lung | Non-Small Cell Lung Carcinoma | Cancer of the LungUnited States
-
Revolution Medicines, Inc.RecruitingAdvanced Solid Tumors | Non-small Cell Lung Cancer (NSCLC) | Pancreatic Ductal Adenocarcinoma (PDAC) | Colorectal Cancer (CRC)United States
-
National Cancer Institute (NCI)TerminatedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
PharmaMarCompletedBreast Cancer | Small Cell Lung Cancer | Ovarian Cancer | Non-small Cell Lung Cancer | Head and Neck Carcinoma | Gynecological Cancer | Non-squamous Cell Lung CancerUnited States, Spain, Switzerland
-
Bristol-Myers SquibbNo longer availableNon-squamous Non-Small Cell Lung Cancer | Squamous Non-Small Cell Lung CancerBrazil, Canada
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingStage III Lung Cancer AJCC v8 | Stage II Lung Cancer AJCC v8 | Limited Stage Lung Small Cell Carcinoma | Stage I Lung Cancer AJCC v8United States, Japan
-
Columbia UniversityTerminatedNon-Small Cell Lung CancerUnited States
-
NeoImmuneTechRoche Pharma AGActive, not recruitingCarcinoma, Non-Small-Cell Lung | Non-Small Cell Lung Cancer | Non Small Cell Lung Cancer | Nonsmall Cell Lung Cancer | Non-Small Cell Lung CarcinomaUnited States
-
National Cancer Institute (NCI)TerminatedStage IIIA Non-Small Cell Lung Cancer | Stage IIA Non-Small Cell Lung Carcinoma | Stage IIB Non-Small Cell Lung Carcinoma | Stage IA Non-Small Cell Lung Carcinoma | Stage IB Non-Small Cell Lung CarcinomaUnited States
-
GlaxoSmithKlineCompletedLung Cancer, Small CellUnited States, Poland
-
Eisai Inc.CompletedNon-small Cell Lung CancerSpain, United States, Canada, Austria, France, Germany
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI); American College of RadiologyCompleted
-
Mirati Therapeutics Inc.RecruitingAdvanced Non-Small Cell Lung Cancer | Metastatic Non-Small Cell Lung CancerUnited States, Korea, Republic of, Italy, Spain, Czechia, Hungary, Netherlands, Canada, Australia, Austria, Belgium, Germany, Ireland, Israel, Poland, United Kingdom, Taiwan, Portugal
-
University of CologneWithdrawnMelanoma | Non Small Cell Lung CancerGermany
-
Eisai Inc.Quintiles, Inc.CompletedNon Small Cell Lung CancerUkraine, Germany, United States, Italy, Czechia
-
Memorial Sloan Kettering Cancer CenterRecruitingSmall Cell Lung Carcinoma | Small Cell Lung CancerUnited States
-
Calithera Biosciences, IncTerminatedNon-Small Cell Lung Cancer | Squamous Non-small-cell Lung Cancer | NFE2L2 Gene Mutation | Squamous Non-Small Cell Neoplasm of LungUnited States
-
OSI PharmaceuticalsCompletedNon-small Cell Lung CancerUnited States, Hungary, Spain, Taiwan, Korea, Republic of, Italy, United Kingdom, Canada, Australia, Belgium, Germany, Austria, Poland, Romania, Argentina, France, Czech Republic, Greece, Russian Federation
-
Bristol-Myers SquibbActive, not recruitingAdvanced Solid Tumors | Non-small Cell Lung CancerUnited States, Italy, Australia, Poland, Spain
-
Celgene CorporationCompletedNon-Small Cell Lung CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedLung CancerUnited States